See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2022_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 90,788,694 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 368,842 |
| 3 | remainder_Assets | 3,189,112 |
| 4 | LiabilitiesCurrent | 11,824,390 |
| 5 | LiabilitiesNoncurrent | 918,607 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,343,814 |
| 9 | ResearchAndDevelopmentExpense | 48,467,113 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 2,360,880 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 94,346,648 |
| 1 | Liabilities | 12,742,997 |
| 2 | Expenses | 65,810,927 |
| 3 | Revenues | 2,360,880 |
| 4 | StockholdersEquity | 81,603,651 |
| 5 | NetIncome | -63,450,047 |
| 6 | ComprehensiveNetIncome | -63,450,047 |
| 7 | BaseVar | 87,630,726 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.14 |
| 9 | EconomicCapitalRatio | 3.12 |
Edgar->Model Mapping
Feature Distribution
Change over Time
